Hannah is a Trainee Solicitor in EIP Legal. Prior to joining EIP she spent five years as an IP litigation paralegal at a specialist IP firm where she was primarily involved in contentious life sciences disputes with a focus on complex patent litigation in the pharmaceutical and biotechnology fields. Hannah has been involved in some of the most high-profile recent cases in these sectors, including Eli Lilly & Others v Genentech, Astex v AstraZeneca and GSK v Wyeth.
Hannah holds a master’s degree in Management of Intellectual Property and a research master’s in Molecular Cell Biology. She also completed the Graduate Diploma in Law and the Legal Practicing Course at BPP University while working full time. Hannah is a native Swedish speaker.
Experience
- Eli Lilly & Others v Genentech: Lead paralegal for Genentech in a declaration of non-infringement and SPC invalidation action concerning Lilly’s originator product ixekizumab (Taltz).
- Astex v AstraZeneca: Lead paralegal for AZ in the successful appeal of the first instance decisions concerning a R&D collaboration agreement for BACE inhibitors for Alzheimer's disease.
- GSK v Wyeth: Lead paralegal for Wyeth in the successful defence of a high value revocation and declaration of non-infringement action concerning Wyeth’s Meningitis B vaccine Trumenba.
Education and qualifications
-
2018 — 2019
Legal Practice Course, BPP University -
2014 — 2016
Graduate Diploma in Law, BPP University -
2012 — 2013
MSc Management of Intellectual Property, Queen Mary University of London -
2011 — 2012
MSc by Research Molecular Cell Biology, University of Edinburgh -
2008 — 2011
BSc Medical Biochemistry, University of Leicester
Career history
- 2019 — present
Trainee Solicitor , EIP - 2014 — 2019
IP Litigation Paralegal, Marks & Clerk Solicitors
Languages spoken
- Swedish (Fluent)